Bristol Myers Squibb (BMS), a global biopharmaceutical leader, and Accenture, a digital transformation specialist, have jointly launched Mosaic an AI-powered healthcare content platform based in Mumbai. This new hub is designed to aggregate, personalise and deliver relevant medical, scientific and educational content to healthcare professionals, patients and stakeholders across therapeutic areas.

At its core, Mosaic leverages artificial intelligence and machine learning to process vast amounts of clinical data, research findings, treatment guidelines and patient education resources. Using smart classification and natural language understanding, the platform helps users quickly find curated, up-to-date content that aligns with their informational needs and context whether that’s clinical insights for practitioners or simplified explanations for patients and caregivers.

According to leadership from both organisations, the platform addresses a critical challenge in healthcare: discovering validated, trustworthy information amidst an ever-expanding universe of medical content. By using AI to personalise content flows and surface relevant resources, Mosaic aims to support evidence-based care delivery, continuous medical education and informed decision-making.

The launch reflects broader trends in digital health where data literacy, personalised engagement and intelligent content delivery are becoming essential to professional and patient communication. With a focus on accuracy, usability and context relevance, the Mosaic hub is positioned to help bridge knowledge gaps, reduce time to information, and support clinical practice improvements across disease areas.

Mumbai was chosen as a strategic base given its position as a key healthcare, technology and business hub in India. BMS and Accenture emphasised that the platform will continue to evolve, with future enhancements potentially supporting multilingual access, regional customisation and deeper integration with clinical workflows and digital care ecosystems.